Global Market for Equipment used in Biotechnology Applications
January 04, 2010
Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKET FOR EQUIPMENT USED IN BIOTECHNOLOGY APPLICATIONS (BIO070A) from BCC Research (www.bccresearch.com), the global market value for biotechnology equipment is an estimated $5.5 billion in 2009, but is expected to increase to nearly $7.3 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 5.8%.
The largest segment of the market, imaging, is expected to increase at a 5-year CAGR of 4.9%, from $1.7 billion in 2009 to $2.1 billion in 2014.
The second-largest segment, electrophoresis, is expected to reach a value of $1.2 billion in 2014. The market in 2009 is estimated at more than $966 million. Thus, the 5-year CAGR is projected to be 4.9%.
The segment projected to see the largest growth from 2009 to 2014 is array. It is expected to increase from an estimated $326 million in 2009 to more than $504 million in 2014, for a 5-year CAGR of 9.1%.
SUMMARY FIGURE
GLOBAL BIOTECHNOLOGY EQUIPMENT MARKET BY TECHNOLOGY, 2007-2014
($ MILLIONS)
To Contact us, click here 
Source: BCC Research
The biotechnology equipment market includes the instruments used in separation, purification, and analysis of biomolecules in drug discovery and diagnostics. The market growth of biotechnology instruments has been driven by the growth in drug discovery research, which itself follows the increased demand for newer drugs and therapies worldwide. Moreover, the end of the human genome project has marked revolutions in genomics and proteomics, thus enhancing global research on genes, proteins, and related biomolecules.
The technology market includes chromatography, electrophoresis, sequencers and synthesizers, laboratory automation, an array market, immunoassay, imaging, and mass spectrometry. The end-user market examined in this report includes biopharmaceuticals, academic institutions, government, agriculture, food and beverages, environmental testing labs, gene/protein expression, toxicogenomics, toxicoproteomics, pharmacogenomics, pharmacoproteomics, HTS screening, life science and clinical imaging.
The intended audience for the report would be professionals in pharmaceutical and biotechnology companies, analytical instrument manufacturers, distributors and suppliers, pharmaceutical and biotechnology associations, and contract research organizations.
The Global Market for Equipment Used in Biotechnology Applications( BIO070A )
Publish Date: Jan 2010
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
The Global Market for Equipment Used in Biotechnology Applications
Customize This Report More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum